Alligator Bioscience AAQS 2024

Alligator Bioscience làm gì?

Alligator Bioscience AB is a biopharmaceutical company based in Lund, Sweden. The company was founded in 2001 and specializes in the development of innovative cancer therapies that harness the body's immune system to fight tumor cells. The company's business model is based on the research, development, and commercialization of biological drugs using highly specialized technologies such as antibody research and immuno-oncology. Alligator Bioscience works closely with leading research institutions and partners in the biotechnology and pharmaceutical industries. Its main focus is on developing antibodies against cancer using its patented technology platforms ALLIGATOR-GOLD® and ALLIGATOR-FAB®. These antibodies are highly effective, safe, and have a low side effect profile. Another important area of Alligator Bioscience's work is immuno-oncology, which involves activating and enhancing the body's own immune system to target and destroy cancer cells. The company has developed a range of innovative drugs in various stages of clinical development. One of its key products is ATOR-1017, a monoclonal antibody that targets the OX40 T-cell receptor and has shown promising results in activating the immune system against cancer in clinical trials. ADC-1013, an antibody targeting the PD-1 receptor, is another promising drug in development for the treatment of various types of cancer. Alligator Bioscience has a diverse portfolio of products and drugs focused on fighting cancer and works closely with research partners and customers to improve the effectiveness and safety of its products for market release. In summary, Alligator Bioscience is a leading company in cancer research and therapy, with an innovative technology platform and highly specialized drugs that have shown promising results. The company is continuously working to develop new and better cancer therapies. Alligator Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.